The Dementia Journal Club led by Dr, Ben Albensi is featuring Dr. P. Hemachandra Reddy from Texas Tech University. All are welcome. Information:
May 9th 11:00 AM Eastern Time (US and Canada)
https://nova.zoom.us/j/97537065873?pwd=clB6VWRpRjFhcFVpN3RuaVNxbzZJdz09
Meeting ID: 975 3706 5873
Passcode: 239509
Bio: P. Hemachandra Reddy, Ph.D., is the Tenured Professor and Vice Chair Research of Basic and Translational Sciences Internal Medicine and Professor of Pharmacology & Neuroscience, Neurology, Public Health and Speech, Language and Hearing Departments at Texas Tech University Health Sciences Center in Lubbock. Dr. Reddy is also an adjunct Professor of Nutritional Sciences Department of Human Sciences at Texas Tech University, in Lubbock. Dr. Reddy is an elected fellow of the American Neurological Association (2014), and an elected Fellow of American Association for the Advancement of Sciences (2020). Received Bharath Gaurav Award from Government of India (2016). Dr. Reddy has published two Books with Elsevier - 1) Molecular Biology of Aging in 2017 and 2) COVID-19 in Alzheimer's Disease and Dementia in 2023. He was formerly an Executive Director and Chief Scientific Officer of the Garrison Institute on Aging (2014-2019) and former Associate Scientist (2009-2014) in the Division of Neuroscience at the Oregon National Primate Research Center, affiliated with Oregon Health & Sciences University. Dr. Reddy received his http://b.sc/ B.Sc. and http://m.sc/ M.Sc. in biology from Sri Venkateswara University, Tirupati, India, and he received an M. Phil in human cytogenetics from Delhi University. As a commonwealth scholar (1990-1993), he was awarded a PhD (1994) in human genetics from the University College, London. Dr. Reddy received postdoctoral training (1995-2000) at the National Human Genome Research Institute of the National Institutes of Health. He was a standing member of the Veteran Affairs Merit Review Study Section (2007-2010), and NIH study section, Neuronal Oxidative Metabolism and Death (2013-2019) and served on several NIH study sections. He received funding from NIH since 2002. Currently he is the principal investigator to 2 NIH R01 grants, 2 R56 grants. Dr. Reddy is the Co-inventor and Chief Scientific Officer of Lubbock-based small business company, abSynapTEX, LLC. Recently, abSynapTEX, LLC received an STTR award from NIH. Dr. Reddy is a prolific writer, author or co-author of more than 260 peer-reviewed articles/chapters/reviews, including publications in such journals as Nature Genetics, Redox Biology, Aging Cell, Ageing Research Reviews, Trends in Neurosciences, Trends in Molecular Medicine, Drug Discovery Today and Human Molecular Genetics. As indicated on the Google Scholar website https://lnkd.in/guXJZ2h8 https://lnkd.in/guXJZ2h8 (accessed April, 2023, Google Scholar search), Dr. Reddy's articles have received over 26,410 citations with an H-Index of 84 and an i10-Index of 179.